PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia.
Fcγ receptor (FcγR) signalling in monocyte derived macrophages from persistent lymphocytic leukaemia (CLL) sufferers is poorly understood. This signalling pathway is the important thing determinant of the flexibility of the macrophages to reply to therapeutic antibodies in present scientific use … Read More